Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Free Cash Flow (2020 - 2025)

iSpecimen has reported Free Cash Flow over the past 6 years, most recently at $82623.0 for Q4 2025.

  • Quarterly results put Free Cash Flow at $82623.0 for Q4 2025, up 102.74% from a year ago — trailing twelve months through Dec 2025 was -$4.2 million (up 48.88% YoY), and the annual figure for FY2025 was -$4.2 million, up 48.87%.
  • Free Cash Flow for Q4 2025 was $82623.0 at iSpecimen, up from -$3.0 million in the prior quarter.
  • Over the last five years, Free Cash Flow for ISPC hit a ceiling of $82623.0 in Q4 2025 and a floor of -$6.1 million in Q3 2021.
  • Median Free Cash Flow over the past 5 years was -$1.7 million (2022), compared with a mean of -$2.1 million.
  • Biggest five-year swings in Free Cash Flow: soared 104.84% in 2023 and later plummeted 3917.17% in 2024.
  • iSpecimen's Free Cash Flow stood at -$1.3 million in 2021, then fell by 23.8% to -$1.6 million in 2022, then soared by 104.84% to $79015.0 in 2023, then plummeted by 3917.17% to -$3.0 million in 2024, then skyrocketed by 102.74% to $82623.0 in 2025.
  • The last three reported values for Free Cash Flow were $82623.0 (Q4 2025), -$3.0 million (Q3 2025), and -$192234.0 (Q2 2025) per Business Quant data.